OFFICIALS LEGISLATION INTEREST GROUPS PUBLIC STATEMENTS COMMITTEES VETOES

Ranking Member Cassidy, Colleagues Oppose Biden Proposal to Illegally Seize Drug Patents

Letter

Date: March 3, 2024
Location: Washington, D.C.
Issues: Health and Health Care

BREAK IN TRANSCRIPT

“A short-sighted decision to exercise march-in rights would work against your stated goal and jeopardize patient access by discouraging individuals from partnering with NIH to develop new cures and treatments. Not only will this hurt patients, but it will also diminish the return the public gets on the investments Congress makes in NIH each year – something we should all seek to optimize.

We share the bipartisan goal of wanting to lower drug prices for American patients and families. But using march-in rights to address drug prices would do more harm than good,” continued the senators. “Agencies, including NIH, should not abuse their authorities to illegally seize intellectual property, and in the process jeopardize the valuable public-private partnerships that make our biomedical research enterprise the best in the world.”

BREAK IN TRANSCRIPT


Source
arrow_upward